AKTS
Aktis OncologyANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
AKTS vs peer average
95/100
AKTS vs. peer average (A vs. D)
Grade spread
B 1 · D 5 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
BLFS is the first available peer comparator.
Similar market capitalization and sector classification, but the packet does not establish modality or indication overlap; useful for small-cap life-science risk context rather than operating read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AKTS
Aktis Oncology
BLFS
BioLife Solutions
Grade
A
B
Momentum
97
65
Value
46
56
Sentiment
61
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs BLFS
AKTS / BLFS
Grade Position
Above peers
AKTS vs. peer average (A vs. D)
95/100
Momentum
97
AKTSValue
46
BLFSSentiment
61
AKTSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AKTS
BLFS is the first peer returned for this comparison set.

